CRMAX
Price
$10.81
Change
+$0.04 (+0.37%)
Updated
Sep 15 closing price
Net Assets
136.94M
VEXAX
Price
$158.86
Change
+$0.38 (+0.24%)
Updated
Sep 15 closing price
Net Assets
81.53B
Interact to see
Advertisement

CRMAX vs VEXAX

Header iconCRMAX vs VEXAX Comparison
Open Charts CRMAX vs VEXAXBanner chart's image
CRM Small/Mid Cap Value I
Price$10.81
Change+$0.04 (+0.37%)
VolumeN/A
Net Assets136.94M
Vanguard Extended Market Index Admiral
Price$158.86
Change+$0.38 (+0.24%)
VolumeN/A
Net Assets81.53B
CRMAX vs VEXAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
CRMAX vs. VEXAX commentary
Sep 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRMAX is a Hold and VEXAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEXAX has more cash in the bank: 81.5B vs. CRMAX (137M). VEXAX pays higher dividends than CRMAX: VEXAX (1.07) vs CRMAX (0.28). CRMAX was incepted earlier than VEXAX: CRMAX (21 years) vs VEXAX (25 years). CRMAX (1.21) is less costly to investors than VEXAX (0.05). CRMAX is a more actively managed with annual turnover of: 72.00 vs. VEXAX (11.00). CRMAX has a lower initial minimum investment than VEXAX: CRMAX (2500) vs VEXAX (3000). VEXAX annual gain was more profitable for investors over the last year : 18.14 vs. CRMAX (-10.01). VEXAX return over 5 years is better than : 61.80 vs. CRMAX (1.92).
CRMAXVEXAXCRMAX / VEXAX
Total Expense Ratio1.210.052,420%
Annual Report Gross Expense Ratio1.210.052,420%
Fund Existence21 years25 years-
Gain YTD-0.55410.159-5%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets137M81.5B0%
Annual Yield % from dividends0.281.0726%
Returns for 1 year-10.0118.14-55%
Returns for 3 years7.0851.9814%
Returns for 5 years1.9261.803%
Returns for 10 years-18.89150.29-13%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SHPAX19.34N/A
N/A
Saratoga Health & Biotechnology A
JBAFX31.81N/A
N/A
JHancock Balanced R4
AREWX26.29N/A
N/A
American Century Real Estate R
GMZPX38.23N/A
N/A
Goldman Sachs Large Cap Gr Insghts P
BISVX14.04N/A
N/A
Brown Advisory Sustainable Val Inv